Torchmark Corporation Announces Third Quarter 2018 Earnings Release And Conference Call

MCKINNEY, Texas, Oct. 15, 2018 /PRNewswire/ -- Torchmark Corporation (NYSE: TMK) will release Third Quarter 2018 earnings after the market closes on Wednesday, October 24, 2018. At that time a copy of the Company's Q3-2018 earnings press release and any other financial and statistical information about the quarter will be available on the Company's website at www.torchmarkcorp.com on the Investors page. In conjunction with Torchmark's Third Quarter 2018 Earnings Release, you are invited to listen to a conference call that will be broadcast live over the Internet on Thursday, October 25, 2018 at 11:00 am Eastern (10:00 am Central).

Third Quarter Conference CallThursday, October 25, 201811:00 a.m. (Eastern)

Listen live and as a replay at www.torchmarkcorp.comon the Investors /Calls and Meetings page under "Conference Calls on the Web" and as a replay under "Conference Call Replays and Transcripts"

or

Call-In Number:

334-323-0522

(Pass Code: Torchmark)

Torchmark Corporation is a holding company specializing in life and supplemental health insurance for "middle income" Americans marketed through multiple distribution channels including direct response, and exclusive and independent agencies. Torchmark has several nationally recognized insurance subsidiaries. Globe Life And Accident is a direct-response provider of life insurance known for its administrative efficiencies. American Income Life provides individual life insurance to working families. Liberty National Life is one of the oldest traditional life insurers in the Southeast. United American is a consumer-oriented provider of supplemental life and health insurance. Family Heritage Life provides individual supplemental health insurance.

View original content:http://www.prnewswire.com/news-releases/torchmark-corporation-announces-third-quarter-2018-earnings-release-and-conference-call-300731326.html

SOURCE Torchmark Corporation

Latest Press Release on General News

Precision oncology company Flindr Therapeutics announces €20 million Series A financing to advance first-in-class small molecule inhibitors

V-Bio Ventures leads international syndicate which includes Johnson & Johnson Innovation – JJDC, Inc., QBIC Fund, Flanders Future Tech Fund, Curie Capital as well as seed investor...

Rett Syndrome Research Trust Partners with Vivalink to Shift Symptom Assessment Paradigms in Rett Syndrome

Vivalink's remote patient monitoring solutions accelerate research into rare neurological disorder CAMPBELL, Calif. , April 23, 2024 /PRNewswire/ -- Vivalink , a leading pro...

World IBS Day - April 19th: Raising Awareness for Everyone with IBS

Debunking myths about Irritable Bowel Syndrome TORONTO , April 18, 2024 /PRNewswire/ -- IBS is a chronic gastrointestinal disorder with symptoms like abdominal pain, bloating,...

Important step taken on the Canada Disability Benefit in Budget 2024, but funding falls short

More work must be done to lift Canadians with disabilities out of poverty TORONTO , April 17, 2024 /CNW/ - The federal government has taken an important step on the Canada Di...

Hydrinity Accelerated Skin Science Introduces MicroFusion Technology and Expands Facial Skincare Line with PRELUDE Facial Treatment Cleanser and HYDRI-C Vitamin C Moisturizer

The Next Generation Technology with the Power to Transform Skin MONROE, La. , April 15, 2024 /PRNewswire/ -- Hydrinity Accelerated Skin Science announced today the launch of t...